CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2012
Cash flows from operating activities:
Net income including noncontrolling interests	$ 51,545	$ 57,868	$ 32,628
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	12,233	10,608	11,408
Write-down of inventories	5,586	2,621	1,772
Foreign currency transactional losses	1,403	511
Deferred income taxes	4,169	(16,161)	(8,691)
Gain on sale of asset held for sale	(1,526)		(747)
Stock-based compensation	3,787	2,888	1,675
Excess (tax benefit) from stock-based compensation	(915)	(1,657)	(214)
Stock donation		2,653
Changes in assets and liabilities:
Trade receivables	(7,304)	(766)	(3,086)
Inventories	(19,077)	(2,371)	19,152
Other current assets	(5,141)	(5,332)	6,820
Accounts payable	11,581	(11,728)	11,783
Accrued liabilities	(4,171)	(3,153)	7,733
Accrued payroll and benefits	(1,887)	1,519	6,512
Income taxes payable	7,054	1,161	(280)
Other non-current assets	(5,752)	(3,112)	(819)
Other non-current liabilities	2,931	3,232	416
Net cash provided by operating activities	54,516	38,781	86,062
Cash flows from investing activities:
Capital expenditures	(16,707)	(15,978)	(8,170)
Trademarks	(285)	(285)	(203)
Short term investments	(33,099)
Proceeds from asset held for sale	2,196		1,165
Net cash (used in) investing activities	(47,895)	(16,263)	(7,208)
Cash flows from financing activities:
Stock options exercised and other changes	(305)	1,575	1,373
Excess tax benefit from stock-based compensation	915	1,657	214
Stock repurchase	(10,488)
Purchase of incremental ownership of U.K. joint venture		(4,689)
Distribution of noncontrolling interests earnings		(234)	(127)
Dividends paid	(6,637)	(36,684)	(2,985)
Net cash (used in) financing activities	(16,515)	(38,375)	(1,525)
Effect of exchange rate changes on cash and cash equivalents	(336)	1,545	1,856
Net (decrease) / increase in cash and cash equivalents	(10,230)	(14,312)	79,185
Cash and cash equivalents at beginning of year	167,889	182,201	103,016
Cash and cash equivalents at end of year	$ 157,659	$ 167,889	$ 182,201